VENETOCLAX IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY SOLID TUMORS: UPDATED FINDINGS FROM A PHASE 1 STUDY

被引：0

作者：

Morgenstern, Daniel ^{[1
,2
]}

Khaw, Seong ^{[3
]}

Gerber, Nicolas ^{[4
]}

Place, Andrew ^{[5
]}

Corradini, Nadege ^{[6
]}

Loh, Mignon ^{[7
]}

Verschuur, Arnauld ^{[8
]}

Ziegler, David ^{[9
,10
,11
]}

Fraser, Chris ^{[12
]}

Cooper, Todd ^{[7
]}

Forlenza, Christopher ^{[13
]}

O'Brien, Maureen ^{[14
]}

Federico, Sara ^{[15
]}

Van Eijkelenburg, Natasha ^{[16
]}

Onishi, Maika ^{[17
]}

Unnebrink, Kristina ^{[18
]}

Chen, Xin ^{[19
]}

Badawi, Mohamed ^{[20
]}

Ghanim, Majd ^{[21
]}

Palenski, Tammy ^{[22
]}

Goldsmith, Kelly ^{[23
]}

机构：

[1] Hosp Sick Children, Toronto, ON, Canada

[2] Univ Toronto, Dept Paediat, Toronto, ON, Canada

[3] Royal Childrens Hosp, Paediat Oncol, Parkville, Vic, Australia

[4] Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland

[5] Dana Farber Boston Childrens Canc & Blood Disorde, Pediat Hematol Oncol, Boston, MA USA

[6] Univ Lyon, Leon Berard Canc Ctr, Inst Paediat Haematol & Oncol IHOPe, Dept Paediat Oncol, Lyon, France

[7] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA

[8] Hop Enfants La Timone, AP HM, Pediat Hematol & Oncol, Marseille, France

[9] Univ New South Wales, Childrens Canc Inst, Lowy Canc Res Ctr, Sydney, NSW, Australia

[10] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia

[11] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia

[12] Lady Cilento Childrens Hosp, Paediat Oncol, Brisbane, Qld, Australia

[13] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA

[14] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA

[15] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA

[16] Princess Maxima Ctr Pediat Oncol, Dept Solid Tumors, Utrecht, Netherlands

[17] Genentech Inc, Prod Dev Hematol, San Francisco, CA USA

[18] AbbVie Deutschland GmbH & Co KG, Data & Stat Sci, Ludwigshafen, Germany

[19] AbbVie Inc, Stat, N Chicago, IL USA

[20] AbbVie Inc, Clini Pharmacol & Pharmacometr, N Chicago, IL USA

[21] AbbVie Inc, Oncol, N Chicago, IL USA

[22] AbbVie Inc, Oncol Dev, N Chicago, IL USA

[23] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Atlanta, GA USA

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O145

引用

页数：2

共 50 条

[21] Updated Results from Phase 1 Study of Targeted Radiotherapy with Lintuzumab-Ac225 in Combination with Venetoclax in Relapsed/Refractory AML
Roboz, Gail J.
Finn, Laura E.
Orozco, Johnnie J.
Hegazi, Mohamed
Desai, Avinash
Chen, Mary
Schiller, Gary J.
BLOOD, 2023, 142
[22] A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
Cash, Thomas
Jonus, Hunter C.
Tsvetkova, Maya
Beumer, Jan Hendrik
Lee, Jasmine Y.
Henry, Curtis
Aguilera, Dolly
Harvey, R. Donald
Goldsmith, Kelly C.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23] A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
Mascarenhas, Leo
Malogolowkin, Marcio
Armenian, Saro H.
Sposto, Richard
Venkatramani, Rajkumar
PEDIATRIC BLOOD & CANCER, 2013, 60 (07) : 1103 - 1107
[24] A PHASE 1/2 STUDY OF AVAPRITINIB FOR KIT- OR PDGFRA-MUTANT PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS
Chi, Susan
Hsieh, Antony
Foley, Megan
Shi, Hongliang
Swamy, Preethi
Rodstrom, Jill
Rudoltz, Marc
NEURO-ONCOLOGY, 2021, 23 : 47 - 47
[25] Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors
Vo, Kieuhoa T.
Karski, Erin E.
Nasholm, Nicole M.
Allen, Shelly
Hollinger, Fabienne
Gustafson, W. Clay
Long-Boyle, Janel R.
Shiboski, Stephen
Matthay, Katherine K.
DuBois, Steven G.
ONCOTARGET, 2017, 8 (14) : 23851 - 23861
[26] A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLL
Crombie, Jennifer L.
Tyekucheva, Svitlana
Savell, Alexandra
Francoeur, Karen
Choiniere, Mark
Montegaard, Josie
Soumerai, Jacob D.
Arnason, Jon E.
Fisher, David C.
Brown, Jennifer R.
Davids, Matthew S.
BLOOD, 2019, 134
[27] A phase I study of oxaliplatin and etoposide in pediatric patients with refractory solid tumors
McGregor, L. M.
Spunt, S. L.
Santana, V. M.
Stewart, C. F.
Ward, D. A.
Wu, J.
Watkins, A.
Ivy, S. P.
Furman, W. L.
Fouladi, M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[28] A PHASE I STUDY OF NAB-PACLITAXEL COMBINED WITH GEMCITABINE FOR PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS
Metts, Jonathan
Ginn, Kevin
Cost, Carrye
Froug, Brittani
Watt, Amanda
Schink, Melissa
Senn, Stacy
Cash, Thomas
PEDIATRIC BLOOD & CANCER, 2022, 69 : S319 - S320
[29] Phase I study of DMP 840 in pediatric patients with refractory solid tumors
Thompson, J
Pratt, CB
Stewart, CF
Avery, L
Bowman, L
Zamboni, WC
Pappo, A
INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 45 - 49
[30] Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
Spunt, Sheri L.
Grupp, Stephan A.
Vik, Terry A.
Santana, Victor M.
Greenblatt, David J.
Clancy, Jill
Berkenblit, Anna
Krygowski, Mizue
Ananthakrishnan, Revathi
Boni, Joseph P.
Gilbertson, Richard J.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) : 2933 - 2940

← 1 2 3 4 5 →